BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Regorafenib
1
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
8/10/2022 1:14:37 PM | Browse: 243 | Download: 487
2
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness
4/15/2022 9:40:09 AM | Browse: 334 | Download: 607
3
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
10/16/2019 12:17:24 PM | Browse: 665 | Download: 696
4
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM | Browse: 837 | Download: 1112
5
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1019 | Download: 1224
6
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 967 | Download: 1344
7
Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
6/13/2016 9:14:00 AM | Browse: 1093 | Download: 1791
8
New active drugs for the treatment of advanced colorectal cancer
12/24/2015 8:55:00 AM | Browse: 872 | Download: 1365
9
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1073 | Download: 1423
10
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1073 | Download: 1145
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345